The use of marijuana for the treatment of medical conditions is a highly controversial topic. Misconceptions by both patients and providers concerning the safety of and evidence-based indications for marijuana can complicate treatment planning and outcomes. Maintaining skills such as motivational interviewing, providing evidence-based informed consent, and increasing access to care remain top priorities for providing quality patient care. The goal of this article is to offer guidance to clinical providers who are adapting to the changing realities of medical marijuana and legalized recreational marijuana.
LENOUE: Adult and Child/Adolescent Psychiatrist currently pursuing a Clinical and Research Fellowship in Addiction Psychiatry at the University of Colorado School of Medicine, Aurora, CO, under the mentorship of Dr Christian Thurstone
WONGNGAMNIT: Medical Director of the Substance Abuse Treatment Program at the Denver Veterans Affairs Medical Center and an Instructor at the Department of Psychiatry, University of Colorado School of Medicine, Aurora, CO
THURSTONE: Adult, Child/Adolescent, and Addiction Psychiatrist at Denver Health and Hospital Authority, where he is Medical Director of the Substance Treatment, Education, and Prevention (STEP) Program. He is an Associate Professor of Psychiatry at the University of Colorado School of Medicine, Aurora, CO
The authors declare no conflicts of interest.
Please send correspondence to: Sean R. LeNoue, MD, 13001 E. 17th Place, Campus P.O. Box F546, Building 500, Room E2322, Aurora, CO 80045. email@example.com.